Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
The Trump administration has released $600 million in appropriated funds for Gavi to support global vaccine efforts in poor countries. This funding aims to improve access to safer vaccine alternatives.
Jul 30, 2026•11 days ago
GenevaBiotechnologyHealth CareNon Profit
Description
The Trump administration is unfreezing $600 million in funds for Gavi, which helps the world’s poorest countries buy vaccines. This decision follows previous safety concerns raised by the U.S. Health Secretary. Gavi is committed to transitioning to mercury-free vaccines
Company Information
Company
Gavi
Location
Geneva, Geneva, Switzerland
About
Gavi is a global vaccination alliance dedicated to increasing access to immunization in the world's poorest countries. It helps secure funding and delivery of vaccines to protect children from preventable diseases such as measles and diphtheria. The organization works with governments, global organizations, and businesses to ensure equitable access to vaccines. Gavi is known for supporting innovative approaches to vaccine delivery and focusing on transitioning to safer, mercury-free alternatives.
GenevaBiotechnologyHealth CareNon Profit